Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals shares declined 9.16 percent on volume of over 20.0 million shares traded Friday to close at $7.63 a share. The company announced it has withdrawn its European marketing application for its weight loss drug Belviq and plans to resubmit it at a later date.
Going forward ... (see research report)
Subscribe to News Feeds